Revival Healthcare Capital LLC (“Revival”) is a Delaware limited liability company formed in April 2018. The principal owners of Revival are Rick Anderson and Lauren Forshey (together, the “Managing Members”). Related persons of Revival act as general partners and/or managers of the Funds (the “Affiliates”). Revival provides investment management and advisory services to the following private investment funds (the “Funds”).
• RVLHC I, LP (referred to as “Fund I”), is a special purpose vehicle formed to make a Commercial Scale Strategy investment in a single portfolio company. Commercial Scale Strategy focuses on funding scale and expansion initiatives early in a company’s commercial lifecycle. Fund I is a master fund for RVLHC Group I, LP.
• RVLHC Group I, LP (referred to as “Group Fund”) is a friends and family vehicle formed exclusively as a feeder fund for Fund I.
• RVLHC II, LLC (referred to as “Fund II”) was formed as a pooled investment vehicle to make Strategic Growth Strategy investments. Strategic Growth Strategy focuses on financing a target company that is sourced by a potential future acquirer of such target company through value inflection milestones where the potential acquirer has a motivated interest and/or structural rights to acquire the target company.
• RVLHC III, LP (referred to as “Fund III”) was formed as a pooled investment vehicle to co-invest in most or all future investment opportunities pursued and consummated by Revival or its Affiliates, including other Funds managed by Revival. Follow-on investments in the Fund I portfolio company are excluded from Fund III. Fund III is the only current fund with the ability to co-invest alongside Fund II. The Funds primarily focus on investing in growth strategies in companies in the medical device and diagnostics sectors (the “Portfolio Companies”). The Funds primarily hold equity and equity-oriented securities of privately held companies, but Revival has broad and flexible investment authority

to structure investments in various financial instruments and securities, including publicly-traded securities. The Funds may make such investments directly or indirectly via separate entities established for legal, tax, regulatory or other reasons, by the relevant Affiliate. The limited partners and members in all Funds are collectively referred to herein as “Investors” and each individually as an “Investor”. The terms of each Fund, including fees, reporting, certain limitations on investing, and other such terms, were negotiated prior to each Investor’s investment in the applicable Fund and are detailed in the limited partnership agreement or limited liability company agreement of each Fund; such documents, agreements, letters, and other items describing fund structure are referred to herein as the “Governing Documents.” The Governing Documents of each Fund sets forth such Fund’s investment objectives and strategy, including guidelines and restrictions regarding the types of securities in which the Funds will invest. Revival tailors its investment advice to the Affiliate of each Fund in accordance with the investment objectives and strategy as set forth in the Governing Documents of each Fund. Revival has entered into a joint venture with the sole investor in Fund II (the “Fund II Investor”) whereby investment discretion for the Fund is shared between Revival and the Fund II Investor, as further described in the Governing Documents. In accordance with common industry practice, Revival or the Affiliates may in the future enter into “side letters” or similar agreements with certain investors pursuant to which Revival or the Affiliates grant the investor specific rights, benefits, or privileges that are not made available to investors generally. Revival does not participate in any wrap fee programs. As of December 31, 2023, Revival manages approximately $70,443,132 of regulatory assets on a discretionary basis and approximately $530,920,819 of regulatory assets on a non-discretionary basis.